GOT2 and pancreatic neoplasm: Additionally, SIRT3 impedes the malate-aspartate shuttle by deacetylating glutamate oxaloacetate transaminase 2 (GOT2), curtailing glycolysis and thus inhibiting the growth of pancreatic tumor cells 54.